In esophageal neoplasms, the histopathologic differentiation between Barrett's esophagus
with or without intraepithelial neoplasia and adenocarcinoma is often challenging …

Barrett's columnar epithelium with dysplasia is the most important risk factor for
adenocarcinoma of the distal esophagus. The molecular mechanisms responsible for …

Background: Barrett's mucosa is a risk factor for esophageal adenocarcinoma and should be
detected at an early stage. CDX2 and liver—intestine (LI)-cadherin are intestine-specific …

Barrett's mucosa is a risk factor for esophageal adenocarcinoma and should be detected at
an early stage. It is defined by the presence of columnar epithelium with goblet cells in the …

Aims Although intestinal‐type epithelium in Barrett's oesophagus has been traditionally
recognized as having a distinct malignant potential, whether this also holds true for cardiac …

Barrett's esophagus, which is histologically characterized by metaplastic columnar
epithelium, is a common condition observed in approximately 10–20% of patients with …

Background Histological assessment of dysplasia in Barrett's esophagus (BE) has high inter-
observer variability. Hence, use of ancillary markers for early detection of dysplasia in BE is …

Background Mucin immunoexpression in adenocarcinoma arising in Barrett's esophagus
(BE) may indicate the carcinogenesis pathway. The aim of this study was to evaluate …

ABSTRACT Objective: The description of Barrett's esophagus which is a risk factor for
esophageal adenocarcinoma has differences, and the need of goblet cells for diagnosis is …

Barrett's esophagus is a premalignant condition associated with gastroesophageal reflux
disease, and consists of mucosa with a metaplastic columnar epithelium (specialized …